Targeting the Expression of Cathepsin B Using CRISPR/Cas9 System in Mammalian Cancer Cells
- 10 January 2018
- book chapter
- Published by Springer Nature
- Vol. 1731, 123-131
Abstract
Cathepsin B belongs to a family of cathepsins and plays an important role in normal physiological functions in the cell. However, overexpression of cathepsin B has been associated with different malignancies, and this has made it an attractive pharmacological target. The advent of CRISPR-Cas9 technology has allowed researchers to efficiently knock down genes with very less nonspecific activity compared to earlier methods. The protocol described below will enable investigators to develop cathepsin B knockdown stable cells and explains ways to study the knockdown.Keywords
This publication has 10 references indexed in Scilit:
- Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patientsMolecular Cancer, 2016
- Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasisMolecular Carcinogenesis, 2015
- Selective Targeting of Tumor and Stromal Cells By a Nanocarrier System Displaying Lipidated Cathepsin B InhibitorAngewandte Chemie International Edition, 2014
- Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinomaMolecular Cancer, 2013
- Cathepsin B as a cancer targetExpert Opinion on Therapeutic Targets, 2013
- Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleftBiochemical Journal, 2004
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivoFEBS Letters, 1991
- Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginaseInternational Journal of Cancer, 1977
- PURIFICATION AND PROPERTIES OF BEEF SPLEEN CATHEPSIN BJournal of Biological Chemistry, 1957